Shandong Xinhua Pharmaceutical Company Limited (XIN) — Capital Reinvestment Ratio
Shandong Xinhua Pharmaceutical Company Limited (XIN) has a Capital Reinvestment Ratio of 1.44x as of September 2023, meaning it reinvests 1% of its operating cash flow (€56.11 Million) in capital expenditures (€80.69 Million). Check Shandong Xinhua Pharmaceutical Company L tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Xinhua Pharmaceutical Company Limited Capital Reinvestment Ratio (2013–2025)
This chart tracks Shandong Xinhua Pharmaceutical Company Limited's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see Shandong Xinhua Pharmaceutical Company L (XIN) cash conversion ratio.
Annual Capital Reinvestment Ratio for Shandong Xinhua Pharmaceutical Company Limited (2013–2025)
Year-by-year Capital Reinvestment Ratio for Shandong Xinhua Pharmaceutical Company Limited from 2013 to 2025. See free cash flow generation of Shandong Xinhua Pharmaceutical Company L to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | €533.73 Million | €115.60 Million | ▼ -62.5% |
| 2024 | 0.58x | €367.61 Million | €212.42 Million | ▼ -52.9% |
| 2023 | 1.23x | €265.28 Million | €325.13 Million | ▲ +279.7% |
| 2022 | 0.32x | €758.24 Million | €244.76 Million | ▼ -66.4% |
| 2021 | 0.96x | €259.12 Million | €249.23 Million | ▲ +44.2% |
| 2020 | 0.67x | €420.19 Million | €280.19 Million | ▼ -36.6% |
| 2019 | 1.05x | €348.27 Million | €366.51 Million | ▼ -12.2% |
| 2018 | 1.20x | €323.91 Million | €388.44 Million | ▲ +79.1% |
| 2017 | 0.67x | €389.97 Million | €261.11 Million | ▲ +29.6% |
| 2016 | 0.52x | €439.35 Million | €227.07 Million | ▲ +6.6% |
| 2015 | 0.48x | €348.64 Million | €169.09 Million | ▼ -35.4% |
| 2014 | 0.75x | €346.34 Million | €260.17 Million | ▼ -77.1% |
| 2013 | 3.28x | €104.99 Million | €344.53 Million | — |